USFDA completes inspection at Raleigh Plant, North Carolina of Aurobindo Pharma's step-down subsidiary

22 Sep 2022 , 11:53 AM

Aurobindo Pharma Limietd has informed to the stock exchanegs regarding completion of USFDA Inspection at Raleigh Plant, North Carolina, owned by Aurolife Pharma LLC, a wholly owned step-down subsidiary of the Company.

In a regulatory filing, the company said that the plant at Raleigh, North Carolina, USA owned by Aurolife Pharma LLC has received an establishment inspection report (EIR) mentioning the inspection a voluntary action initiated (VAI) from the United States Food and Drug Administration (US FDA).

With this, the USFDA pre-approval inspection and GMP inspection are concluded, the company said on Thursday.

At around 11:52 AM, Aurobindo Pharma Ltd is currently trading at Rs522 per share down by Rs3.15 or 0.6% from its previous closing of Rs525.15 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]